HoldingsChannel.com
BioRestorative Therapies insider buying image
The table below summarizes the most recent BioRestorative Therapies insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why BioRestorative Therapies insider buys are important for investors to follow.
DateInsiderPriceAmount
4-9-2024
Insider Buy		 Francisco Silva
VP of Research and Development		 $1.23
CAGR » 		$10,229.32
8,308 shares
2-9-2024
Insider Buy		 Dale Broadrick
 $1.29
CAGR » 		$206,022.87
160,000 shares
2-8-2024
Insider Buy		 Dale Broadrick
 $1.35
CAGR » 		$162,254.96
120,000 shares
9-15-2023
Insider Buy		 Lance Alstodt
President, CEO, COB		 $1.70
CAGR » 		$3,740.00
2,200 shares
9-15-2023
Insider Buy		 Dale Broadrick
 $1.60
CAGR » 		$32,000.00
20,000 shares
9-7-2023
Insider Buy		 Dale Broadrick
 $2.07
CAGR » 		$5,165.00
2,500 shares
9-13-2023
Insider Buy		 Lance Alstodt
President, CEO, COB		 $1.53
CAGR » 		$1,226.00
800 shares
9-6-2023
Insider Buy		 Lance Alstodt
President, CEO, COB		 $1.96
CAGR » 		$5,658.52
2,887 shares
8-31-2023
Insider Buy		 Francisco Silva
VP of Research and Development		 $2.22
CAGR » 		$10,997.88
4,954 shares
7-27-2023
Insider Buy		 Dale Broadrick
 $2.80
CAGR » 		$2,800.00
1,000 shares
7-25-2023
Insider Buy		 Lance Alstodt
President, CEO, COB		 $2.44
CAGR » 		$10,248.00
4,200 shares
3-31-2023
Insider Buy		 Francisco Silva
VP of Research and Development		 $3.56
CAGR » 		$2,659.32
747 shares
2-22-2023
Insider Buy		 Dale Broadrick
>10% Owner		 $2.86
CAGR » 		$17,705.00
6,200 shares
2-1-2023
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.10
CAGR » 		$1,241.36
400 shares
1-27-2023
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.01
CAGR » 		$602.00
200 shares
1-20-2023
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.13
CAGR » 		$627.00
200 shares
1-18-2023
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.11
CAGR » 		$1,244.30
400 shares
1-9-2023
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.08
CAGR » 		$308.00
100 shares
12-23-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.01
CAGR » 		$903.00
300 shares
12-7-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $2.99
CAGR » 		$5,374.98
1,800 shares
11-18-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $2.88
CAGR » 		$2,876.50
1,000 shares
10-12-2022
Insider Buy		 Francisco Silva
VP of Research and Development		 $3.39
CAGR » 		$2,456.59
725 shares
10-11-2022
Insider Buy		 Francisco Silva
VP of Research and Development		 $3.69
CAGR » 		$2,973.01
806 shares
9-23-2022
Insider Buy		 Dale Broadrick
>10% Owner		 $2.83
CAGR » 		$848.97
300 shares
9-22-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $2.92
CAGR » 		$584.00
200 shares
8-29-2022
Insider Buy		 Francisco Silva
VP of Research and Development		 $3.28
CAGR » 		$18,776.74
5,723 shares
7-13-2022
Insider Buy		 Dale Broadrick
>10% Owner		 $3.01
CAGR » 		$3,610.99
1,200 shares
7-12-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $2.95
CAGR » 		$2,065.00
700 shares
6-30-2022
Insider Buy		 Dale Broadrick
>10% Owner		 $3.08
CAGR » 		$5,849.91
1,900 shares
6-30-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.10
CAGR » 		$3,407.91
1,100 shares
6-21-2022
Insider Buy		 Dale Broadrick
>10% Owner		 $3.79
CAGR » 		$2,649.94
700 shares
6-15-2022
Insider Buy		 Robert Eugene Kristal
Chief Financial Officer		 $3.61
CAGR » 		$700.34
194 shares
6-15-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.68
CAGR » 		$2,577.54
700 shares
6-13-2022
Insider Buy		 Dale Broadrick
>10% Owner		 $3.92
CAGR » 		$5,096.52
1,300 shares
6-14-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.91
CAGR » 		$1,955.95
500 shares
6-13-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.95
CAGR » 		$790.00
200 shares
6-10-2022
Insider Buy		 Dale Broadrick
>10% Owner		 $4.25
CAGR » 		$6,805.68
1,600 shares
6-8-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $4.28
CAGR » 		$428.00
100 shares
6-6-2022
Insider Buy		 Dale Broadrick
>10% Owner		 $4.92
CAGR » 		$20,676.78
4,200 shares
6-7-2022
Insider Buy		 Robert Eugene Kristal
Chief Financial Officer		 $4.56
CAGR » 		$912.00
200 shares
6-2-2022
Insider Buy		 Dale Broadrick
>10% Owner		 $4.69
CAGR » 		$4,687.80
1,000 shares
6-1-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $4.60
CAGR » 		$920.00
200 shares
5-26-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.52
CAGR » 		$9,494.01
2,700 shares
5-2-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.95
CAGR » 		$1,578.80
400 shares
4-8-2022
Insider Buy		 Robert Eugene Kristal
Chief Financial Officer		 $5.71
CAGR » 		$43,396.00
7,600 shares
4-5-2022
Insider Buy		 Dale Broadrick
>10% Owner		 $5.71
CAGR » 		$262,640.00
46,000 shares
1-24-2022
Insider Buy		 Lance Alstodt
President, CEO, COB		 $3.40
CAGR » 		$4,998.00
1,470 shares
12-1-2021
Insider Buy		 Lance Alstodt
President, CEO, COB		 $5.50
CAGR » 		$4,394.50
799 shares
11-22-2021
Insider Buy		 Lance Alstodt
President, CEO, COB		 $6.31
CAGR » 		$2,498.76
396 shares
11-19-2021
Insider Buy		 Francisco Silva
VP of Research and Development		 $6.66
CAGR » 		$26,626.00
4,000 shares
11-16-2021
Insider Buy		 Lance Alstodt
President, CEO, COB		 $6.71
CAGR » 		$30,201.00
4,500 shares
1-6-2020
Insider Buy		 Dale Broadrick
>10% Owner		 $0.01
CAGR » 		$102,812.31
8,460,210 shares
12-9-2019
Insider Buy		 Dale Broadrick
>10% Owner		 $0.03
CAGR » 		$67,587.58
2,088,852 shares
8-22-2019
Insider Buy		 Dale Broadrick
>10% Owner		 $0.28
CAGR » 		$48,909.96
176,820 shares
9-9-2019
Insider Buy		 Lance Alstodt
EVP and Chief Strategy Officer		 $0.26
CAGR » 		$5,220.00
20,000 shares
9-6-2019
Insider Buy		 Mark Weinreb
CEO and Chairman of the Board		 $0.25
CAGR » 		$5,530.25
22,000 shares
9-4-2019
Insider Buy		 Francisco Silva
VP of Research and Development		 $0.24
CAGR » 		$5,017.95
20,955 shares
9-5-2019
Insider Buy		 Lance Alstodt
EVP and Chief Strategy Officer		 $0.27
CAGR » 		$2,697.50
10,000 shares
8-30-2019
Insider Buy		 Francisco Silva
VP of Research and Development		 $0.28
CAGR » 		$4,989.50
18,000 shares
8-28-2019
Insider Buy		 A. Jeffrey Radov
Director		 $0.28
CAGR » 		$1,649.70
6,000 shares
8-28-2019
Insider Buy		 Paul Jude Tonna
Director		 $0.27
CAGR » 		$19,180.00
70,000 shares
8-26-2019
Insider Buy		 A. Jeffrey Radov
Director		 $0.26
CAGR » 		$1,539.60
6,000 shares
8-27-2019
Insider Buy		 Lance Alstodt
EVP and Chief Strategy Officer		 $0.28
CAGR » 		$2,761.00
10,000 shares
8-22-2019
Insider Buy		 Mark Weinreb
CEO and Chairman of the Board		 $0.26
CAGR » 		$1,312.30
5,000 shares
8-22-2019
Insider Buy		 Dale Broadrick
>10% Owner		 $0.28
CAGR » 		$49,164.29
175,017 shares
8-22-2019
Insider Buy		 Francisco Silva
VP of Research and Development		 $0.26
CAGR » 		$4,445.80
17,374 shares
8-21-2019
Insider Buy		 Lance Alstodt
EVP and Chief Strategy Officer		 $0.25
CAGR » 		$2,498.00
10,000 shares
5-9-2018
Insider Buy		 Robert B. Catell
Director		 $2.80
CAGR » 		$14,000.00
5,000 shares
2-9-2017
Insider Buy		 Francisco Silva
VP of Research and Development		 $4.56
CAGR » 		$19,348.50
4,245 shares
9-26-2016
Insider Buy		 John M. Desmarais
Director and >10% Owner		 $3.00
CAGR » 		$240,000.00
80,000 shares
5-18-2016
Insider Buy		 Robert B. Catell
Director		 $4.00
CAGR » 		$50,000.00
12,500 shares
3-1-2016
Insider Buy		 Robert B. Catell
Director		 $4.00
CAGR » 		$150,000.00
37,500 shares
12-7-2015
Insider Buy		 Charles S. Ryan
Director		 $4.00
CAGR » 		$25,000.00
6,250 shares
5-8-2015
Insider Buy		 Charles S. Ryan
Director		 $0.25
CAGR » 		$50,000.00
200,000 shares
8-1-2014
Insider Buy		 Paul Jude Tonna
Director		 $0.25
CAGR » 		$30,000.00
120,000 shares
6-30-2014
Insider Buy		 Joseph B. Swiader
Director		 $0.25
CAGR » 		$25,000.00
100,000 shares
12-13-2011
Insider Buy		 Antonio Joel San
Director		 $0.00
CAGR » 		$7,500.00
7,500,000 shares
12-13-2011
Insider Buy		 Mark Weinreb
CEO and Chairman of the Board		 $0.00
CAGR » 		$35,000.00
35,000,000 shares
12-13-2011
Insider Buy		 A. Jeffrey Radov
Director		 $0.00
CAGR » 		$7,500.00
7,500,000 shares

Also See: Institutional Holders of BRTX
Also See: SEC filings

BRTX Performance Since Insider Purchase
Below we present the annualized performance delivered by BioRestorative Therapies stock since 4-9-2024 (the date of the most recent insider purchase). The performance of the investment from the time BioRestorative Therapies insider buying occurred is the ultimate test of whether insiders were right about BRTX being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 04/10/2024
End date: 05/03/2024
Start price/share: $1.30
End price/share: $1.36
Dividends collected/share: $0.00
Total return: 5.00%
Annualized Gain: 79.35%
Starting investment: $10,000.00
Ending investment: $10,500.00
Years: 0.06

BioRestorative Therapies Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent BioRestorative Therapies insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding BRTX

BRTX — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree BRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

BRTX — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the BioRestorative Therapies Insider Buying occurred are:

Bogota Financial Insider Buying
First Trust Intermediate Duration Preferred and Income Fund Insider Buying
Mexco Energy Insider Buying
Martin Midstream Partners LP Insider Buying
Aileron Therapeutics Insider Buying
Dominari Holdings Insider Buying
Entrada Therapeutics Insider Buying
Annexon Insider Buying
Oncternal Therapeutics Insider Buying
Heritage Insurance Holdings Insider Buying

BioRestorative Therapies Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.